Navigation Links
ZIOPHARM Presents Unique Mechanism Data for Indibulin at AACR

LOS ANGELES--(BUSINESS WIRE)--Apr 16, 2007 - ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) presented preclinical data yesterday on indibulin (ZIO-301) at the American Association of Cancer Research (AACR) meeting in Los Angeles. These data demonstrate that indibulin has distinct biologic and molecular properties from other tubulin binding agents and strongly suggest a very different toxicity profile, particularly with regard to peripheral neuropathy. While indibulin binds to tubulin in general, it does not bind to neuronal specific tubulin and does not disrupt normal axonal microtubules in vitro, likely accounting for the difference with regard to neurotoxicity.

Indibulin is one of a class of cancer therapeutics that includes the taxanes (paclitaxel and docetaxel) and Vinca alkaloids, some of the most widely used anti-cancer agents in the world today. In spite of their effectiveness, all of the commercially available agents exhibit some degree of neurotoxicity that in many cases can be dose limiting.

Indibulin, like the taxanes and vinca alkaloids, interferes with the function of microtubules by binding to their building blocks, tubulin. However, the specific tubulin binding site for indibulin is different from that of taxanes and Vinca alkaloids. The observed lack of neurotoxicity in animals receiving indibulin treatment is thought to be related to this difference in binding site, and in particular to the observation that indibulin does not bind to neuronal-specific tubulin. Indibulin is active across a diverse range of human, mouse, and rat tumor cell lines in vitro and in human tumor xenografts, including glioblastoma and in drug-resistant tumor cell lines.

"We are very excited about indibulin's potential," commented Brian Schwartz, M.D., Chief Medical Officer at ZIOPHARM. "The fact that it is orally available and shows no signs of the neurotoxicity in preclinical models associated with other agents i
'"/>




Page: 1 2 3

Related medicine technology :

1. ZIOPHARM to Present at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
2. ZIOPHARM Presents Data Highlighting Oral ZIO-101 at AACR
3. ZIOPHARM Presents Data on Orally Active ZIO-201 at AACR
4. ZIOPHARM Presents ZIO-201 Lymphoma Data at ISH
5. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
6. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
7. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
8. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
9. Tranzyme Pharma Presents Initial Phase IIa Data for its Novel Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis
10. Novagali Pharma Presents at AACO the Results of its Pivotal Phase III Clinical Trial of Vekacia in Children Suffering From Vernal Keratoconjunctivitis
11. BioLife Solutions Presents Data on CryoStor at International Society for Cellular Therapy Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: ZIOPHARM Presents Unique Mechanism Data for Indibulin AACR
(Date:9/15/2014)... HAMILTON, N.J. , Sept. 15, 2014 /PRNewswire-iReach/ ... Bennett , University of South Carolina, submitted a ... FDA Commissioner, asking the FDA to add another ... antibiotic drug labels.  This request asks for a ... events:  "toxic psychoses, hallucinations, paranoia, suicidal thoughts or ...
(Date:9/15/2014)... and BRUSSELS , Sept. 15, 2014 ... UCB (Euronext Brussels:UCB) today announced results from several exploratory ... postmenopausal women with low bone mineral density (BMD). Romosozumab ... work by inhibiting the protein sclerostin, thereby increasing bone ... at the American Society for Bone and Mineral Research ...
(Date:9/15/2014)... DALLAS , Sept. 15, 2014 /PRNewswire-iReach/ -- MedicOne ... ambulance transport services, has been selected by Inc. ... companies in America. Photo - ... Inc. 500|5000 list identifies successful, privately-held companies with ... MedicOne Medical Response, one of only two ambulance ...
Breaking Medicine Technology:Quinolone Vigilance Foundation Supports Citizen Petition Requesting Another Black Box Warning for Levaquin, Cipro, Avelox 2Quinolone Vigilance Foundation Supports Citizen Petition Requesting Another Black Box Warning for Levaquin, Cipro, Avelox 3New Analyses Of Phase 2 Study Presented At ASBMR Show Romosozumab Treatment Resulted In Continued Increases In Bone Mineral Density 2New Analyses Of Phase 2 Study Presented At ASBMR Show Romosozumab Treatment Resulted In Continued Increases In Bone Mineral Density 3New Analyses Of Phase 2 Study Presented At ASBMR Show Romosozumab Treatment Resulted In Continued Increases In Bone Mineral Density 4New Analyses Of Phase 2 Study Presented At ASBMR Show Romosozumab Treatment Resulted In Continued Increases In Bone Mineral Density 5New Analyses Of Phase 2 Study Presented At ASBMR Show Romosozumab Treatment Resulted In Continued Increases In Bone Mineral Density 6New Analyses Of Phase 2 Study Presented At ASBMR Show Romosozumab Treatment Resulted In Continued Increases In Bone Mineral Density 7New Analyses Of Phase 2 Study Presented At ASBMR Show Romosozumab Treatment Resulted In Continued Increases In Bone Mineral Density 8New Analyses Of Phase 2 Study Presented At ASBMR Show Romosozumab Treatment Resulted In Continued Increases In Bone Mineral Density 9New Analyses Of Phase 2 Study Presented At ASBMR Show Romosozumab Treatment Resulted In Continued Increases In Bone Mineral Density 10New Analyses Of Phase 2 Study Presented At ASBMR Show Romosozumab Treatment Resulted In Continued Increases In Bone Mineral Density 11New Analyses Of Phase 2 Study Presented At ASBMR Show Romosozumab Treatment Resulted In Continued Increases In Bone Mineral Density 12New Analyses Of Phase 2 Study Presented At ASBMR Show Romosozumab Treatment Resulted In Continued Increases In Bone Mineral Density 13New Analyses Of Phase 2 Study Presented At ASBMR Show Romosozumab Treatment Resulted In Continued Increases In Bone Mineral Density 14New Analyses Of Phase 2 Study Presented At ASBMR Show Romosozumab Treatment Resulted In Continued Increases In Bone Mineral Density 15MedicOne Medical Response Named to 2014 Inc. 5000 Fastest Growing Companies List 2MedicOne Medical Response Named to 2014 Inc. 5000 Fastest Growing Companies List 3
(Date:9/16/2014)... 16, 2014 DiaperBuys, a national online ... Aging’ Month this September. Healthy Aging Month was started ... the nation on the positive aspects of growing older. ... conditions or side effects from medications that cause urinary ... Manager for DiaperBuys.com. “This can seem daunting to some ...
(Date:9/16/2014)... 2014 Banish headaches forever with the ... Cefaly device for chronic migraine relief and treatment. Cefaly ... United States. Until now, US patients would directly place ... Belgium and wait 2-3 weeks for their device to ... States and once prescription and payment is received, the ...
(Date:9/16/2014)... Reading, MA (PRWEB) September 16, 2014 ... announce its partnership with Fairfax Egg Bank. The collaboration ... and expand the donor egg offering at the Fertility ... operated since 2006 and offers the nation’s largest selection ... is advantageous for several reasons:, , ...
(Date:9/15/2014)... Missouri (PRWEB) September 16, 2014 The ... at Carey Danis & Lowe report that ... Corp., was found responsible for the injuries that a ... sling to treat stress urinary incontinence (SUI). , Carey ... defective medical device litigation and personal injury law. The ...
(Date:9/15/2014)... (PRWEB) September 16, 2014 Hastings and ... in Phoenix Arizona announces one flat attorney fee for ... that clients retain the largest portion possible of their ... expenses, lost wages and damaged personal property. In addition, ... to clients that simply states that no fees are ...
Breaking Medicine News(10 mins):Health News:DiaperBuys Honors ‘Healthy Aging’ Month throughout September 2Health News:DiaperBuys Honors ‘Healthy Aging’ Month throughout September 3Health News:Cefaly Migraine Treatment Device Now Readily Available For Widespread Purchase in United States 2Health News:FCNE Announces Partnership with Fairfax Egg Bank 2Health News:Carey Danis & Lowe Reports On $73 Million Boston Scientific Verdict 2Health News:Hastings And Hastings Announces One Flat Attorney Fee For Personal Injury Cases 2Health News:Hastings And Hastings Announces One Flat Attorney Fee For Personal Injury Cases 3
... highlight the dangers of infection from live birds, report ... peanut butter contaminated with salmonella has dominated the headlines ... is also prevalent in live poultry. , The Jan. ... and Prevention,s Morbidity and Mortality Weekly Report ...
... in a patient,s immune system that may lead to safer therapies ... as potential new ways to treat transplant rejection. , ... ... an abnormality in a patient,s immune system that may lead to ...
... Calif., Jan. 22 The following is a statement ... SEIU Trusteeship Hearing Officer Ray Marshall ruled against ... the founding of the Service Employees International Union in ... President the right to take over a local union. ...
... 22 Methodist Dallas Medical Center has been named ... in Community Service Award. The hospital is being honored ... The award was presented Jan. 22 at THA,s annual ... has screened more than 50,000 men since 2000, when ...
... in Financial Malpractice, Lays Out Recommendations to Protect Members ... Together for ChangeWASHINGTON, Jan. 22 In his Report ... on the trusteeship matter involving United Healthcare Workers - ... Marshall, the outside hearing officer, found that "Leaders of ...
... 22 At a meeting of its Board of Directors, ... on both the Common and Preferred Stock of the Company.A ... shares of Common Stock was declared payable on March 2, ... on February 13, 2009. In addition, a dividend of ...
Cached Medicine News:Health News:Salmonella Common In U.S. Poultry 2Health News:Salmonella Common In U.S. Poultry 3Health News:UCSF Finds Potential New Antibody Treatment for Autoimmune Diseases 2Health News:UCSF Finds Potential New Antibody Treatment for Autoimmune Diseases 3Health News:UHW Statement on Ray Marshall Trusteeship Recommendations 2Health News:Methodist Health System Prostate Cancer Screening Program Wins Statewide Community Service Award 2Health News:Methodist Health System Prostate Cancer Screening Program Wins Statewide Community Service Award 3Health News:SEIU IEB Unanimously Adopts Secretary Marshall's Report; UHW Given 5 Days to Comply with Union's Democratic Process and Decisions 2Health News:SEIU IEB Unanimously Adopts Secretary Marshall's Report; UHW Given 5 Days to Comply with Union's Democratic Process and Decisions 3
... The SmartDriver System consists of a pistol-grip ... Power, with a wide range of couplers ... of orthopedic surgical applications., ,The Battery ... speed compared to the original Battery SmartDriver. ...
... is an evolutionary product for the inside-out ... designed specifically for use with the Collagen ... becoming a new standard for use in ... a unique method to deliver sutures using ...
... Release System is a technological breakthrough in ... a minimally-invasive approach, provides significant patient benefits. ... of the wrist,creates an entry for the ... a standard video camera system, provides a ...
... a safe alternative to using positive displacement ... such as PCR(a), pipetting radioactive materials and ... excellent for tissue culture, gel loading, serological ... aerosol contaminants and liquids from reaching the ...
Medicine Products: